Insights

Gathering insights about SAGE…

Similar companies to SAGE

SAGE Tech Stack

SAGE uses 8 technology products and services including Yardi Voyager, cdnjs, WordPress, and more. Explore SAGE's tech stack below.

Yardi Voyager
Accounting
cdnjs
Content Delivery Network
WordPress
Content Management System
Font Awesome
Font Scripts
Twemoji
Font Scripts
jQuery Migrate
Javascript Libraries
ZURB Foundation
UI Frameworks
jQuery Waypoints
Web Tools And Plugins

Media & News

Sage Therapeutics, Inc. (SAGE) Reports Q2 Loss, Beats Revenue Estimates
Sage Therapeutics, Inc. (SAGE) came out with a quarterly loss of $0.79 per share versus the Zacks Consensus Estimate of a loss of $0.96. This compares to a loss of $1.7 per share a year ago.
Jul 30, 2025 | www.zacks.com
SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Sage Therapeutics, Inc. (NasdaqGM: SAGE) to Supernus Pharmaceuticals, Inc. (NasdaqGM: SUPN). Under the terms of the proposed transaction, Sage shareholders will receive $8.50 per share in cash, plus one non-tradable contingent value right collectively worth up to $3.50 per share in cash payable upon.
Jul 14, 2025 | www.businesswire.com
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Sage Therapeutics, Inc. (NASDAQ: SAGE)
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Sage Therapeutics, Inc. (NASDAQ: SAGE ) related to its sale to Supernus Pharmaceuticals, Inc. Upon completion of the proposed transaction, current Sage shareholders will receive $8.50 per share in cash, plus one non-tradable contingent value right collectively worth up to $3.50 per share in cash payable (i) $0.50 the first commercial sale of the drug Zurzuvae in Japan to third-aprty consumers following regulatory approval on or before June 30, 2026; (ii) $1.00 when net sales of Zurzuvae reach or exceed $300 million in the U.S. on or before December 31, 2028; and (iii) $1.00 when net sales of Zurzuvae reach or exceed $375 million in the U.S. on or before December 31, 2030. Is it a fair deal?
Jul 01, 2025 | www.globenewswire.com
What Makes Sage Therapeutics (SAGE) a New Buy Stock
Sage Therapeutics (SAGE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Jul 01, 2025 | www.zacks.com
Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary
FLORHAM PARK, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced the appointment of Anne Marie Cook, J.D.
Jun 23, 2025 | www.globenewswire.com
SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Sage Therapeutics, Inc. (NasdaqGM: SAGE) to Supernus Pharmaceuticals, Inc. (NasdaqGM: SUPN). Under the terms of the proposed transaction, Sage shareholders will receive $8.50 per share in cash, plus one non-tradable contingent value right collectively worth up to $3.50 per share in cash payable upon.
Jun 18, 2025 | www.businesswire.com
SAGE to be Acquired by Supernus Pharmaceuticals in $795 Million Deal
SUPN inks deal to acquire Sage Therapeutics for up to $795 million, securing rights to depression drug Zurzuvae.
Jun 17, 2025 | www.zacks.com

SAGE's Email Address Formats

SAGE uses at least 1 format(s):

SAGE Email Formats	Example	Percentage
First.Last@sageworld.com	John.Doe@sageworld.com	92%
First@sageworld.com	John@sageworld.com	7%
Last@sageworld.com	Doe@sageworld.com	1%

Frequently Asked Questions

Where is SAGE's headquarters located?

SAGE's main headquarters is located at 6275 West Plano Parkway, Suite 175. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is SAGE's phone number?

You can contact SAGE's main corporate office by phone at

+1-214-631-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is SAGE's stock symbol?

SAGE is a publicly traded company; the company's stock symbol is SAGE.

What is SAGE's official website and social media links?

SAGE's official website is sageworld.com and has social profiles on LinkedIn.

How much revenue does SAGE generate?

As of January 2026, SAGE's annual revenue is estimated to be $7.8M.

What is SAGE's SIC code NAICS code?

SAGE's SIC code is 7371 - Computer Programming Services NAICS code is 5112 - Software Publishers.

How many employees does SAGE have currently?

As of January 2026, SAGE has approximately 151 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Ceo: E. N.Vice President Of Sales: B. B.Vice President Of Information Services: D. F. P.. Explore SAGE's employee directory with LeadIQ.

What industry does SAGE belong to?

SAGE operates in the Software Development industry.

What technology does SAGE use?

SAGE's tech stack includes Yardi VoyagercdnjsWordPressFont AwesomeTwemojijQuery MigrateZURB FoundationjQuery Waypoints.

What is SAGE's email format?

SAGE's email format typically follows the pattern of First.Last@sageworld.com. Find more SAGE email formats with LeadIQ.

When was SAGE founded?

SAGE was founded in 1992.

SAGE

Q: What is SAGE's official website and social media links?

SAGE's official website is sageworld.com. SAGE has social profiles on LinkedIn.

Q: How many employees does SAGE have currently?

SAGE has approximately 151 employees.

Q: What technology does SAGE use?

SAGE's tech stack includes jQuery CDN, reCAPTCHA, Google Tag Manager, MySQL, ZURB Foundation.

Software DevelopmentTexas, United States51-200 Employees

Voted "Promo's Greatest Companies To Work For" 2 years in a row by PPAI Media!

SAGE is the leading provider of research and marketing solutions to the promotional products industry, providing product research and business management services, website and email services, e-commerce solutions, printed end-user catalogs, artwork services, payment processing, tradeshows, and tradeshow services.

SAGE is the exclusive technology provider for members of the Promotional Products Association International (PPAI), the industry’s non-profit association.

Company Overview

Headquarters: 6275 West Plano Parkway, Suite 175
Phone number: +1-214-631-****
Website: sageworld.com
SIC Code: 7371 - Computer Programming Services
Stock Symbol: SAGE
NAICS Code: 5112 - Software Publishers
Founded: 1992
Employees: 51-200

Media & News

Funding & Financials

$100M$250M
SAGE's revenue is estimated to be in the range of $100M$250M

Funding & Financials

$100M$250M
SAGE's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to SAGE

Microsoft

Freshworks

Xero

Ellucian

Salesforce

SAP

Blackbaud

Zoho

Adobe

IBM

Kajabi

Workday

Instructure

Oracle Corporation

SAGE Tech Stack

Media & News

Sage Therapeutics, Inc. (SAGE) Reports Q2 Loss, Beats Revenue Estimates

SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Sage Therapeutics, Inc. (NASDAQ: SAGE)

What Makes Sage Therapeutics (SAGE) a New Buy Stock

Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary

SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE

SAGE to be Acquired by Supernus Pharmaceuticals in $795 Million Deal

SAGE's Email Address Formats

Frequently Asked Questions

Where is SAGE's headquarters located?

What is SAGE's phone number?

What is SAGE's stock symbol?

What is SAGE's official website and social media links?

How much revenue does SAGE generate?

What is SAGE's SIC code NAICS code?

How many employees does SAGE have currently?

What industry does SAGE belong to?

What technology does SAGE use?

What is SAGE's email format?

When was SAGE founded?

SAGE

Company Overview

Media & News

Sage Therapeutics, Inc. (SAGE) Reports Q2 Loss, Beats Revenue Estimates

SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Sage Therapeutics, Inc. (NASDAQ: SAGE)

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?